Global Prostate Cancer Testing Market 2018-2022

Below are some of the key findings from the prostate cancer testing market research report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global prostate cancer testing industry overview

The increasing incidences of prostate cancer is one of the primary factors that will trigger the growth of the prostate cancer testing market in the coming years. The incidence of prostate cancer is increasing worldwide and is the second most common cancer diagnosed in men. It is estimated that every year approximately one million new cases of prostate cancer are diagnosed worldwide. Over the last few decades, the incidence rate of prostate cancer has increased owing to the rising older population, growing urbanization, and associated lifestyle changes. This will further lead the prostate cancer testing market to grow at a CAGR of close to 11% by 2022.

The increasing focus on biomarker research is one of the key trends in the prostate cancer testing market. The development of biomarkers has accelerated with the recent developments in high throughput technology platforms in proteomics, genomics, and immunology. The manufacturers are focusing on developing prostate cancer biomarkers which can foretell disease aggressiveness and drive better treatment decisions.

Top prostate cancer testing companies covered in this market research report

The prostate cancer testing market is moderately fragmented with companies focusing on increasing R&D and investments in the development of innovative products. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this prostate cancer testing industry analysis report will aid clients to form effective business strategies for strengthening their position in the market.

The report offers a complete analysis of various companies including:

• C. R. Bard
• Cook Medical
• Danaher
• F. Hoffmann-La Roche
• MDxHealth
• OPKO Health
• Siemens Healthcare

Prostate cancer testing market segmentation based on geographic regions

• Americas
• APAC
• EMEA

With a complete study of the growth opportunities for the companies, the Americas will account for the highest prostate cancer testing share throughout the forecast period. However, the APAC region is likely to contribute the highest incremental growth during the forecast period primarily due to the presence of a huge patient pool and the growing awareness about prostate cancer.

Prostate cancer testing market segmentation based on product

• Biomarkers
• Biopsy
• Imaging

The biomarkers segment will account for the highest growth in the market primarily supported by the increasing awareness about the clinical benefits of advanced biomarkers. Additionally, the report also provides an accurate prediction of the contribution of the various products segments impacting the growth of the prostate cancer testing market size.

Key highlights of the global prostate cancer testing market for the forecast years 2018-2022:

• CAGR of the market during the forecast period 2018-2022
• Detailed information on factors that will accelerate the growth of the prostate cancer testing market during the next five years
• Precise estimation of the global prostate cancer testing market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• Growth of the prostate cancer testing industry across the Americas, APAC, and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details on the factors that will challenge the growth of prostate cancer testing companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch